Mr. Narula spent 16 years with Pfizer serving in several financial leadership positions, and has worked under the leadership of Pfizer's Chief Financial Officer and Executive Vice President of Business Operations and Global Supply, Frank D'Amelio. At Upjohn, he worked closely with incoming Viatris CEO Michael Goettler and has developed a deep understanding of financial and commercial dynamics across key geographies, including emerging markets, particularly China. He also brings knowledge of the generic and branded pharmaceutical business.
Pfizer Chairman and CEO Dr. Albert Bourla said: "Sanjeev's global experience, proven leadership, and deep industry knowledge will serve Viatris employees, customers and shareholders well. I am very confident that his commitment to excellence will be instrumental as the new company charts its path as a champion for global health."